Adaptive Immunity and MHC

Choose a study mode

Play Quiz
Study Flashcards
Spaced Repetition
Chat to Lesson

Podcast

Play an AI-generated podcast conversation about this lesson

Questions and Answers

A researcher is investigating the dynamics of B cell activation and differentiation during a secondary immune response. Which of the following scenarios would most accurately reflect the expected kinetics and characteristics of antibody production?

  • A rapid and amplified production of IgG antibodies, accompanied by affinity maturation, with a relatively short duration due to apoptosis of effector cells. (correct)
  • A delayed but potent production of IgD antibodies, characterized by low-affinity binding and limited opsonization capabilities, gradually transitioning into IgE.
  • A prolonged lag phase characterized by somatic hypermutation, followed by a gradual increase in IgM production and eventual class switching to IgG, IgA, or IgE.
  • An immediate and robust production of IgM antibodies, sustained over several weeks, with minimal class switching due to limited T cell help.

A patient with a genetic defect exhibits impaired IgA secretion in mucosal linings. Given this deficiency, which of the following immunological challenges would this patient most likely encounter?

  • Heightened vulnerability to helminthic infestations due to the absence of IgE-mediated eosinophil degranulation.
  • Systemic autoimmune reactions due to increased complement activation by circulating immune complexes.
  • Increased susceptibility to intracellular bacterial infections such as _Listeria monocytogenes_.
  • Elevated risk of infection by enteric and respiratory pathogens that colonize mucosal surfaces. (correct)

A novel therapeutic intervention aims to enhance ADCC activity against tumor cells. Which of the following strategies would most effectively augment this process?

  • Inhibition of Fc receptors on NK cells, preventing antibody binding and subsequent degranulation.
  • Engineering bispecific antibodies that simultaneously bind tumor-associated antigens and FcγRIIIa (CD16) on NK cells. (correct)
  • Enhancement of MHC class I expression on tumor cells to facilitate T cell-mediated cytotoxicity.
  • Administration of high-dose corticosteroids to suppress the inflammatory response and prevent bystander damage.

In the context of T cell activation, what is the most precise description of the functional consequence of disrupting the interaction between B7 molecules on antigen-presenting cells (APCs) and CD28 on T cells?

<p>Induction of T cell anergy or apoptosis, resulting in immune tolerance to the presented antigen. (C)</p> Signup and view all the answers

A research team is investigating the mechanisms of CD8+ T cell-mediated cytotoxicity. Which of the following scenarios would most effectively impair the ability of cytotoxic T lymphocytes (CTLs) to induce apoptosis in target cells?

<p>Genetic ablation of perforin and granzymes, while preserving the expression of Fas ligand (FasL). (D)</p> Signup and view all the answers

Consider a scenario where a patient receives a bone marrow transplant from an HLA-mismatched donor. Despite immunosuppressive therapy, the patient develops severe graft-versus-host disease (GVHD). Which of the following immunological mechanisms is most likely driving the pathogenesis of GVHD in this context?

<p>Donor T cells recognizing recipient HLA alloantigens, resulting in a cytotoxic attack on host tissues. (B)</p> Signup and view all the answers

A researcher is designing an experiment to assess the impact of varying cytokine environments on the differentiation of CD4+ T helper cells. Under which specific cytokine milieu would naïve CD4+ T cells most efficiently differentiate into Th1 cells?

<p>Presence of IL-12 and IFN-γ, stimulating the activation of STAT4 and subsequent production of IFN-γ. (C)</p> Signup and view all the answers

A novel mutation in MHC class II molecules results in a significantly reduced ability to present antigens to CD4+ T cells. Which of the following immunological consequences would most likely arise from this mutation?

<p>Impaired activation of B cells and diminished antibody production against T-dependent antigens. (C)</p> Signup and view all the answers

Which of the following scenarios most accurately describes the functional role of the invariant chain (Ii) in MHC class II antigen processing and presentation?

<p>Preventing the premature binding of endogenous peptides to MHC class II molecules in the endoplasmic reticulum and Golgi apparatus. (B)</p> Signup and view all the answers

A patient presents with a rare genetic defect resulting in the complete absence of β2-microglobulin. Which of the following immunological abnormalities would most likely be observed in this individual?

<p>Lack of MHC class I surface expression and impaired CD8+ T cell-mediated cytotoxicity. (C)</p> Signup and view all the answers

A novel drug targets the interaction between the T cell receptor (TCR) and MHC molecules. Which of the following mechanisms would most effectively disrupt this interaction?

<p>Competitive inhibition of the TCR binding site on the MHC molecule with a high-affinity decoy molecule. (A)</p> Signup and view all the answers

Consider a scenario where a patient undergoes a hematopoietic stem cell transplantation (HSCT) but develops delayed immune reconstitution, particularly in T cell numbers. Which of the following strategies would most effectively enhance T cell recovery post-transplant?

<p>Ex vivo expansion of donor-derived T cell precursors followed by adoptive transfer into the recipient. (B)</p> Signup and view all the answers

A research team is investigating the role of non-classical MHC molecules in immune regulation. Which of the following functions is most accurately associated with MHC-E?

<p>Inhibiting NK cell activation by binding to CD94/NKG2A receptors. (A)</p> Signup and view all the answers

A novel immunotherapeutic approach aims to enhance the presentation of tumor-associated antigens (TAAs) on MHC class I molecules. Which of the following strategies would most effectively augment this process?

<p>Enhancement of proteasome activity, promoting the generation of antigenic peptides from intracellular proteins. (A)</p> Signup and view all the answers

Consider a scenario where a patient lacks the ability to undergo somatic hypermutation in B cells. Which of the following immunological consequences would most likely result from this deficiency?

<p>Impaired affinity maturation and reduced ability to generate long-lived plasma cells. (A)</p> Signup and view all the answers

A researcher is investigating the role of autophagy in antigen presentation. Which of the following processes would most likely be facilitated by autophagy in the context of MHC class II presentation?

<p>Transport of cytosolic antigens into lysosomes for degradation and loading onto MHC class II molecules. (C)</p> Signup and view all the answers

A patient presents with a genetic defect that impairs the expression of the co-stimulatory molecule CD86 on antigen-presenting cells (APCs). Which of the following outcomes is most likely?

<p>Impaired activation of T cells, resulting in T cell anergy or tolerance. (A)</p> Signup and view all the answers

A researcher is studying the role of regulatory T cells (Tregs) in maintaining immune homeostasis. Which of the following mechanisms is most likely employed by Tregs to suppress the activity of effector T cells?

<p>Expression of CTLA-4 to outcompete CD28 for binding to B7 molecules on antigen-presenting cells (APCs). (C)</p> Signup and view all the answers

A novel therapeutic strategy involves the use of blocking antibodies against specific cytokines to modulate adaptive immunity. Which of the following cytokine-antibody interactions would be most effective in suppressing Th17-mediated inflammation?

<p>Antibodies against IL-17 to neutralize its pro-inflammatory effects on neutrophils and other target cells. (C)</p> Signup and view all the answers

A patient with a rare immunodeficiency lacks functional TAP proteins. Which of the following immunological impairments is most likely to result from this deficiency?

<p>Reduced MHC class I surface expression and impaired activation of CD8+ T cells. (A)</p> Signup and view all the answers

Flashcards

Humoral Immunity

Immunity mediated by secreted antibodies, defending against extracellular microbes and toxins.

Cell-Mediated Immunity

Adaptive immunity mediated by T cells, eradicating intracellular microbes.

Neutralization (Antibodies)

Antibodies block microbe binding to cells, preventing infection.

Opsonization

IgG antibodies coat microbes, promoting phagocytosis by binding to Fc receptors on phagocytes.

Signup and view all the flashcards

ADCC

Antibodies (IgG or IgE) bind infected cells or parasites, activating NK cells or eosinophils to kill them.

Signup and view all the flashcards

Complement Activation (by Antibodies)

IgG and IgM activate complement, enhancing microbe killing.

Signup and view all the flashcards

Mucosal/Neonatal Immunity (Antibodies)

IgA in mucosal linings neutralizes microbes/toxins; neonatal IgG protects newborns via placenta/milk.

Signup and view all the flashcards

Primary Immune Response

First exposure to antigen; IgM is primary antibody; slow response; short lived.

Signup and view all the flashcards

Secondary Immune Response

Later exposure to same antigen; rapid response; IgG is primary antibody; long lived due to memory cells.

Signup and view all the flashcards

CD4+ T cells' role

CD4+ T cells differentiate, producing cytokines (IL-12 leading to Th1, IL-4 to Th2) to kill intracellular microbes.

Signup and view all the flashcards

Th1 function

Th1 cells secrete IFN-γ activates phagocytes to eradicate microbes.

Signup and view all the flashcards

Th2 function

Th2 cells secrete IL-4 and IL-5 to stimulate eosinophil and mast cell degranulation in allergy and helminthic infection

Signup and view all the flashcards

CD8+ T cells' role

CD8+ T cells kill infected cells via direct cytotoxicity, eliminating the reservoir of infection.

Signup and view all the flashcards

T cell Activation: Signal 1

Peptide + MHC on APC surface, recognized by TCR-CD3 complex.

Signup and view all the flashcards

T cell Activation: Signal 2

Interaction of B7 molecule on APCs with CD28 on T cells.

Signup and view all the flashcards

CD8+ CTL Killing Process

CTLs recognize class I MHC + peptides on infected cells, form tight adhesions, and are activated by IL-2 and IFN-γ to release granules, killing the target cell.

Signup and view all the flashcards

Perforin

Pores in target cell membrane.

Signup and view all the flashcards

Granzymes Function

Enter target cells through pores and induce apoptosis via caspase activation.

Signup and view all the flashcards

MHC Definition

Genes on chromosome 6 producing MHC molecules for antigen presentation to T cells (HLA in humans).

Signup and view all the flashcards

MHC Class I

HLA-A, HLA-B, HLA-C; role in Ag presentation to Tc

Signup and view all the flashcards

MHC Class II

HLA-D region including HLA-DR, HLA-DP, HLA-DQ; role in Ag presentation to Th

Signup and view all the flashcards

Study Notes

  • The module covers foundations of immunology, specifically adaptive immunity and the major histocompatibility complex (MHC).

Adaptive Immunity Overview

  • Adaptive immunity includes humoral and cell-mediated immunity.

Humoral Immunity

  • Humoral immunity is mediated by secreted antibodies.
  • It defends against extracellular microbes and microbial toxins.

Functions of Antibody Isotypes

  • Neutralization: Antibodies block microbe binding to cells, inhibiting infection and spread, and prevent toxins from binding to cellular receptors.
  • Opsonization: IgG antibodies coat microbes, promoting phagocytosis by binding to Fc receptors on neutrophils and macrophages.
  • Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC): IgG binds infected cells via Fab regions, and Fc regions bind Fc receptors on NK cells, activating them to kill the cells. IgE binds helminthic parasites via Fab regions, and Fc regions bind Fc receptors on eosinophils, causing degranulation and parasite death.
  • Complement Activation: IgG and IgM activate the complement system.
  • Mucosal Immunity: IgA in mucosal secretions (GIT and RT) neutralizes microbes and toxins by blocking their entry.
  • Neonatal Immunity: Maternal IgG antibodies are transported across the placenta, and antibodies in ingested milk protect newborns.

Primary Immune Response

  • Upon first exposure to an antigen, there is a lag of about ten days before a specific antibody is detectable.
  • The primary antibody produced is IgM.
  • Antibody levels decline after a short time.

Secondary Immune Response

  • Re-exposure to the same antigen results in a rapid antibody appearance and greater amount.
  • The main antibody class is IgG.
  • Antibodies remain detectable for months or years.
  • Simultaneous exposure to a new antigen leads to a primary response for that antigen.
  • The immune system possesses immunologic memory for antigens.
  • During the primary response, some B lymphocytes become long-lived memory cells.
  • Class switching from IgM to IgG is required for the secondary response.

Cell-Mediated Immunity

  • Cell-mediated immunity eradicates intracellular microbes.
  • Consists of activating naive T cells to proliferate and differentiate into effector cells, including CD4+ T helper cells and CD8+ cytolytic cells (CTLs), which eliminates intracellular microbes

Types of Cell-Mediated Immunity

  • CD4+ T cells differentiate into two effector cells based on cytokine production: IL-12 leads to Th1, and IL-4 leads to Th2.
  • Th1 secretes IFN-γ, which activates phagocytes to kill microbes.
  • Th2 secretes IL-4 and IL-5 stimulating eosinophil and mast cell degranulation in allergy and helminthic infection.

CD8+ T Cells

  • CD8+ T cells kill any cell containing intracellular microbes or microbial proteins through direct cell cytotoxicity, eliminating the reservoir of infection.

T Cell Activation

  • T cells are activated by two signals.
  • Signal 1: Peptide + MHC on APCs is recognized by TCR-CD3.
  • Signal 2: Interaction of B7 molecule on APCs with CD28 on T cells provides a co-stimulatory signal.
  • Absence of the second signal leads to T-cells to enter anergy (unresponsiveness).

Steps of CD8+ CTL Killing

  • CTLs recognize class I MHC + peptides on the surface of infected target cells.
  • Tight adhesions (“conjugates”) are formed with these cells.
  • CTLs are activated by IL-2 & IFN-γ to release their granule contents, leading to granule exocytosis.
  • Granule contents include perforin, which forms pores in the target cell membrane.
  • Granzymes enter cells through the pores and induce apoptosis by activating capases
  • CTL detaches to kill other cells
  • Target cell death occurs.

Major Histocompatibility Complex (MHC)

  • MHC is a group of genes on the short arm of chromosome 6, and these produce MHC molecules.
  • MHC molecules are present on cell surfaces.
  • MHC is responsible for displaying protein antigens to T cells; it is also called human leucocytic Ag = HLA.

Classification of Genes (MHC)

  • Class I MHC genes include HLA-A, HLA-B, and HLA-C and are involved in antigen presentation to Tc cells.
  • Class II MHC genes include HLA-D region genes (HLA-DR, HLA-DP, and HLA-DQ) promoting antigen presentation to Th cells.
  • Class III MHC genes lie between class I & II and produce some complement components and TNF-α but do not produce MHC.

Structure and Distribution of MHC Molecules

  • MHC molecules are membrane proteins expressed on cells.
  • Both class I & II molecules consist of an extracellular part, a transmembrane part, and a cytoplasmic part to anchor the molecule to the cell.

Class I MHC Molecules

  • Two polypeptide chains form Class I MHC molecules.
  • The alpha chain has three domains (α1, α2, α3), attached to β2 microglobulin outside MHC.
  • α1 and α2 domains create a cleft or groove that binds to peptides.
  • It presents antigens to CD8+ T cells.
  • Class I molecules are expressed on all nucleated cells.

Class II MHC Molecules

  • Class II MHC molecules are made of two polypeptide chains, an alpha chain (α1 & α2) and a beta chain (β1 & β2).
  • The α1 and β1 domains form the peptide-binding cleft.
  • Class II is expressed on APCs only.

Additional Information

  • B7 molecules on APCs bind with CD28 on T cells during T cell activation.
  • Class I MHC presents antigen to Th (CD4), NK, Tc (CD8), monocytes and macrophges.

Studying That Suits You

Use AI to generate personalized quizzes and flashcards to suit your learning preferences.

Quiz Team

Related Documents

More Like This

Use Quizgecko on...
Browser
Browser